Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Waterloo

$18,000.00

Statistical and computational model for high dimensional data analysis

FY 2017-18

Summary
Research towards the development of statistical and computational methodologies for analyzing high dimensional data has gained much attention over the last decade. Methodological advances with respect to feature selection, classification, and predication have been widely applied in many fields, such as the drug discovery process, high throughput genomic and genetic data analysis, and infectious disease modeling. A drug is often a small molecule that interacts with the binding sites of some target proteins. The drug discovery process can typically be divided into four main stages: (i) target identification; (ii) lead discovery; (iii) clinical trials; and (iv) regulatory approval and reimbursement. Drug discovery is a time consuming and costly process. Computer-Aided Drug Design (CADD) is a specialized discipline that uses computational statistics models and algorithms to aid the drug discovery process. The long-term objective of my NSERC DG research program is to develop effective and efficient statistical and computational methods for analyzing diverse types of high dimensional data in the CADD areas. In the next 5 years, my short-term objectives are to make advances in three main themes: 1) computational drug discovery: from pharmacoinformatics to pharmacoeconomics via multi-task statistical learning; 2) statistical methods for genetic association studies; and 3) individual-level modeling of infectious diseases in large populations. The proposed research provides new strategies for CADD and will have direct impact on the planning stage of the research and development of new drugs. New territory in the research area of CADD will be explored by using pharmacoeconomics to influence the direction of drug discovery via multi-task statistical learning, detecting gene-gene interactions via genome-wide haplotype-based association analysis, and improving agent-based modeling calibration process by using the approximate Bayesian computation method.
Program
Discovery Grants Program - Individual
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2016-06546
Name nom
Wong, WilliamWaiLun
Department département
Pharmacy, Leslie Dan Faculty of - Pharmacy, Leslie Dan Faculty of
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2016
Award amount
18000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1508
Committee name en
Mathematics and Statistics
Committee name fr
Mathématiques et statistique
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3004
Research subject group en
Statistics and probability
Research subject group fr
Statistique et probabilité
Research subject en
Applied statistics
Research subject fr
Statistique appliquée
Partie
2
Nb partie
5
Application title
Statistical and computational model for high dimensional data analysis
Keyword
NSERC
Application summary
Research towards the development of statistical and computational methodologies for analyzing high dimensional data has gained much attention over the last decade. Methodological advances with respect to feature selection, classification, and predication have been widely applied in many fields, such as the drug discovery process, high throughput genomic and genetic data analysis, and infectious disease modeling. A drug is often a small molecule that interacts with the binding sites of some target proteins. The drug discovery process can typically be divided into four main stages: (i) target identification; (ii) lead discovery; (iii) clinical trials; and (iv) regulatory approval and reimbursement. Drug discovery is a time consuming and costly process. Computer-Aided Drug Design (CADD) is a specialized discipline that uses computational statistics models and algorithms to aid the drug discovery process. The long-term objective of my NSERC DG research program is to develop effective and efficient statistical and computational methods for analyzing diverse types of high dimensional data in the CADD areas. In the next 5 years, my short-term objectives are to make advances in three main themes: 1) computational drug discovery: from pharmacoinformatics to pharmacoeconomics via multi-task statistical learning; 2) statistical methods for genetic association studies; and 3) individual-level modeling of infectious diseases in large populations. The proposed research provides new strategies for CADD and will have direct impact on the planning stage of the research and development of new drugs. New territory in the research area of CADD will be explored by using pharmacoeconomics to influence the direction of drug discovery via multi-task statistical learning, detecting gene-gene interactions via genome-wide haplotype-based association analysis, and improving agent-based modeling calibration process by using the approximate Bayesian computation method.